SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹58,462 Cr | ₹52,578 Cr | ₹48,497 Cr | ₹43,886 Cr | ₹38,654 Cr |
What is the latest Revenue of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹58,462 Cr |
| Mar2025 | ₹52,578 Cr |
| Mar2024 | ₹48,497 Cr |
| Mar2023 | ₹43,886 Cr |
| Mar2022 | ₹38,654 Cr |
How is Revenue of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹58,462 Cr | 11.19 | |
| Mar2025 | ₹52,578 Cr | 8.42 | |
| Mar2024 | ₹48,497 Cr | 10.51 | |
| Mar2023 | ₹43,886 Cr | 13.53 | |
| Mar2022 | ₹38,654 Cr | - | |
Compare Revenue of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,863.5 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| MANKIND PHARMA | ₹102,194.0 Cr | -5.5% | -2.2% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% |
2.4% |
17.1% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses